首页> 外文期刊>The European Journal of Neuroscience >Adenosine A(1) receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D(1) dopamine receptors.
【24h】

Adenosine A(1) receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D(1) dopamine receptors.

机译:腺苷A(1)受体介导的对大鼠纹状体多巴胺释放的抑制作用由D(1)多巴胺受体调节。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dopamine release is regulated by presynaptic dopamine receptors and interactions between adenosine and dopamine receptors have been well documented. In the present study, dopamine release from isolated striatal slices from Wistar rats was measured using fast cyclic voltammetry. Single-pulse stimulation (0.1 ms, 10 V) was applied every 5 min over a 2-h period. Superfusion with the adenosine (A)(1) receptor agonist N(6)-cyclopentyladenosine (CPA), but not the A(2) receptor agonist 3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]p urin-2-yl]amino]ethyl] phenyl]propanoic acid (CGS 21680), inhibited dopamine release in a concentration-dependent manner (IC(50) 3.80 x 10(-7) m; n = 10). The dose-response curve to CPA was shifted to the right (IC(50) 6.57 x 10(-6) m; n = 6, P < 0.05 vs. control) by the A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). Neither the D(1) agonist 6-chloro-APB nor the D(1) antagonist R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3- benzazepine-7-ol (SCH 23390) altered dopamine release on their own. However, SCH 23390 (3 microm) significantly attenuated the response to CPA (IC(50) 1.44 x 10(-5) m; n = 6, P < 0.01 vs. control). Furthermore, the inhibitory effect of CPA was significantly increased in the presence of 6-chloro-APB (1 microm). In radioligand binding experiments, CPA interacted with high- and low-affinity states of [(3)H]DPCPX-lableled A(1) receptors. The high-affinity agonist binding to A(1) receptors was inhibited by the stable guanosine triphosphate analogue Gpp(NH)p. In contrast, neither the proportion nor the affinity of high-affinity A(1) receptors was altered by dopamine or SCH 23390. These results provide evidence that the inihibition of dopamine release by adenosine A(1) receptors is dependent, at least in part, on the simultaneous activation of D(1) dopamine receptors. While the mechanism underlying this interaction remains to be determined, it does not appearto involve an intramembrane interaction between A(1) and D(1) receptors.
机译:多巴胺的释放受突触前多巴胺受体的调节,腺苷和多巴胺受体之间的相互作用已得到充分证明。在本研究中,使用快速循环伏安法测量了Wistar大鼠离体纹状体片中多巴胺的释放。在2小时内每5分钟施加一次单脉冲刺激(0.1 ms,10 V)。腺苷(A)(1)受体激动剂N(6)-环戊基腺苷(CPA)的灌注,但A(2)受体激动剂3- [4- [2-[[6-氨基-9-[(2R) ,3R,4S,5S)-5-(乙基氨基甲酰基)-3,4-二羟基-氧杂戊-2-基] p尿素-2-基]氨基]乙基]苯基]丙酸(CGS 21680),抑制多巴胺的释放浓度依赖的方式(IC(50)3.80 x 10(-7)m; n = 10)。 A(1)受体拮抗剂8-cyclopentyl-1将CPA的剂量反应曲线移至右侧(IC(50)6.57 x 10(-6)m; n = 6,相对于对照,P <0.05) ,3-二丙基黄嘌呤(DPCPX)。 D(1)激动剂6-chloro-APB或D(1)拮抗剂R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3 -苯并ze庚因-7-ol(SCH 23390)自行改变了多巴胺的释放。但是,SCH 23390(3微米)显着减弱了对CPA的响应(IC(50)1.44 x 10(-5)m; n = 6,相对于对照,P <0.01)。此外,在6-氯-APB(1微米)存在下,CPA的抑制作用显着增强。在放射性配体结合实验中,CPA与[(3)H] DPCPX标记的A(1)受体的高亲和力和低亲和力状态相互作用。稳定的结合到A(1)受体的高亲和性激动剂被稳定的鸟苷三磷酸类似物Gpp(NH)p抑制。相反,多亲胺或SCH 23390既不改变高亲和力A(1)受体的比例,也不改变亲和力。这些结果提供了证据,表明腺苷A(1)受体对多巴胺释放的抑制作用是依赖性的,至少部分是依赖,同时激活D(1)多巴胺受体。虽然这种相互作用的机制尚待确定,但似乎不涉及A(1)和D(1)受体之间的膜内相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号